Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-07

Clinical Trial Update: Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ezetimibe to nutraceuticals in statin-intolerant patients with coronary artery disease, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zetia (ezetimibe)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN